These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1103 related articles for article (PubMed ID: 25421010)
1. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related]
2. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
3. Potential circulating miRNA signature for early detection of NSCLC. Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589 [TBL] [Abstract][Full Text] [Related]
4. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
5. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
6. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897 [TBL] [Abstract][Full Text] [Related]
7. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related]
8. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218 [TBL] [Abstract][Full Text] [Related]
9. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
10. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer. Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767 [TBL] [Abstract][Full Text] [Related]
11. A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients. Wang C; Ding M; Xia M; Chen S; Van Le A; Soto-Gil R; Shen Y; Wang N; Wang J; Gu W; Wang X; Zhang Y; Zen K; Chen X; Zhang C; Zhang CY EBioMedicine; 2015 Oct; 2(10):1377-85. PubMed ID: 26629532 [TBL] [Abstract][Full Text] [Related]
12. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers. Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400 [TBL] [Abstract][Full Text] [Related]
13. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer. Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients. Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916 [TBL] [Abstract][Full Text] [Related]
15. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Wang RJ; Zheng YH; Wang P; Zhang JZ Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772 [TBL] [Abstract][Full Text] [Related]
16. Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. Yang JS; Li BJ; Lu HW; Chen Y; Lu C; Zhu RX; Liu SH; Yi QT; Li J; Song CH Tumour Biol; 2015 Apr; 36(4):3035-42. PubMed ID: 25501703 [TBL] [Abstract][Full Text] [Related]
17. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer. Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230 [TBL] [Abstract][Full Text] [Related]
18. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Zhang Y; Zhang Y; Yin Y; Li S Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
20. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]